Average Co-Inventor Count = 11.01
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (22 from 2,405 patents)
2. Msd R&d (china) Co., Ltd. (1 from 10 patents)
3. Xrad Therapeutics, Inc. (1 from 1 patent)
4. Msd R&d Co., Ltd. (0 patent)
23 patents:
1. 12187742 - Dual ATM and DNA-PK inhibitors for use in anti-tumor therapy
2. 11179389 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
3. 10780092 - Fused pyrazine derivatives useful as soluble guanylate cyclase stimulators
4. 10544130 - Metallo-beta-lactamase inhibitors
5. 10544147 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
6. 10428076 - Soluble guanylate cyclase stimulators
7. 10357481 - Substituted triazolo bicyclic compounds as PDE2 inhibitors
8. 10227331 - Metallo-β-lactamase inhibitors
9. 10221163 - Metallo-beta-lactamase inhibitors
10. 10221178 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
11. 10160762 - 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
12. 10100064 - Purine inhibitors of human phosphatidylinositol 3-kinase delta
13. 10072025 - Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors
14. 10059705 - Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
15. 10030027 - Soluble guanylate cyclase stimulators